J&J Climbed 0.85% While the Nasdaq Fell – The Talc Settlement Finally Let the Stock Trade on Its Merits
Johnson & Johnson JNJ gained 0.85% on August 28 as investors rotated into defensive healthcare while the Nasdaq dropped 1.4% following Fed Chair Warsh's Jackson Hole rate-hike signal. The $268.04 close reflects

Follow